Nanalysis Scientific Corp

As of June 30, 2026, Nanalysis Scientific Corp carries a market capitalization of 18.81M, placing it among publicly traded companies globally. Its enterprise value stands at 32.23M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Nanalysis Scientific Corp's next confirmed earnings release is scheduled for December 1, 2026.

As of June 30, 2026, Nanalysis Scientific Corp has 139.34M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.44, and the price-to-book ratio stands at 1.52.

As of June 30, 2026, Nanalysis Scientific Corp trades at an EV/EBITDA multiple of 48.69 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.80 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 32.23M versus a market cap of 18.81M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Nanalysis Scientific Corp maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 113.14, indicating elevated leverage, while an interest coverage ratio of 0.64 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Nanalysis Scientific Corp posted a negative return on equity (ROE) of -33.43, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -11.73, reflecting losses generated across the asset base. The company generates approximately 168,125.00 in revenue per employee across its workforce of 240.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.03 indicates how many times Nanalysis Scientific Corp sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Nanalysis Scientific Corp recorded 16,000.00 in income tax expense. The company reported a pretax loss of -4.16M and -4.18M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 8, 2026, Nanalysis Scientific Corp's stock has declined approximately 45.24% over the past 52 weeks. The 50-day moving average sits at 0.16, while the 200-day moving average is 0.32.

Over the twelve months ended June 30, 2026, Nanalysis Scientific Corp generated 40.35M in revenue and converted that into -4.18M in net income, yielding earnings per share of -0.03. EBITDA reached 662,000.00, while operating income came in at -2.03M.

As of June 30, 2026, Nanalysis Scientific Corp holds 540,000.00 in cash and equivalents against 13.96M in total debt, resulting in a net debt position of 12.24M. Total book value stands at 12.34M, with working capital of 447,000.00 providing operational flexibility.

Nanalysis Scientific Corp produced 2.93M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.08M in capital expenditures, free cash flow totaled 1.85M - equivalent to 0.01 per share.

Over the twelve months ended June 30, 2026, Nanalysis Scientific Corp posted a gross margin of 24.44, reflecting its pricing power and cost economics. The operating margin of -5.02 and net profit margin of -10.35 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Nanalysis Scientific Corp paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 10.51, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 9.54, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Nanalysis Scientific Corp shareholders.

Nanalysis Scientific Corp's most recent stock split took place on June 13, 2019 with a 4:1 split ratio.

As of June 30, 2026, Nanalysis Scientific Corp has an Altman Z-Score of -2.13, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.